Population Pharmacokinetics of Arbekacin, Vancomycin, and Panipenem in Neonates

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1159-1167

  Kimura, Toshimi ^a,e   Sunakawa, Keisuke ^c   Matsuura, Nobuo ^b   Kubo, Hiroaki ^d   Shimada, Shigehiko ^a   Yago, Kazuo ^a  

^a Department of Pharmacy ^*  (Japan)

^b Division of Neonatology   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CREATININE; GLYCOPEPTIDE; HABEKACIN; PANIPENEM; VANCOMYCIN;

ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; FEMALE; GESTATIONAL AGE; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BAYES THEOREM; BODY WEIGHT; CREATININE; DIBEKACIN; FEMALE; GESTATIONAL AGE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; POPULATION; THIENAMYCINS; VANCOMYCIN;

EID: 1642502349     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1159-1167.2004     Document Type: Article

References (49)

1. Albrecht, L. M., M. J. Rybak, L. H. Warbasse, and D. J. Edwards. 1991. Vancomycin protein binding in patients with infections caused by Staphylococcus aureus. DICP = Ann. Pharmacother. 25:713-715.
2. Al-Dahhan, J., G. B. Haycock, C. Chantler, and L. Stimmler. 1983. Sodium homeostasis in term and preterm neonates. I. Renal aspects. Arch. Dis. Child. 58:335-342.
3. Arant, B. S., Jr. 1978. Developmental patterns of renal functional maturation compared in the human neonate. J. Pediatr. 92:705-712.
4. Asbury, W. H., E. H. Darsey, W. B. Rose, J. E. Murphy, D. E. Buffington, and C. C. Capers. 1993. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation. Ann. Pharmacother. 27:490-496.
5. Beal, S. L., A. Beckman, and L. B. Sheiner. 1992. NONMEM users guides, version IV. NONMEM Projects Group, University of California, San Francisco.
6. Bernareggi, A., M. Borgonovi, A. Del Favero, B. Rosina, and L. Gavanaghi. 1991. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers. Eur. J. Drug Metab. Pharmacokinet. 3:256-260.
7. Bleyzac, N., V. Varnier, J. M. Labaune, S. Corvaisier, P. Maire, R. W. Jelliffe, G. Putet, and G. Aulagner. 2001. Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation. Eur. J. Clin. Pharmacol. 57:499-504.
8. Bosso, J. A., G. M. Chan, and J. M. Matsen. 1983. Cefoperazone pharmacokinetics in preterm infants. Antimicrob. Agents Chemother. 23:413-415.
9. Brion, N., A. Contrepois, and C. Carbon. 1983. From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding. Presse Med. 12:293-296.
10. Burstein, A. H., L. E. Wyble, P. Gal, P. R. Diaz, J. L. Ransom, R. Q. Carlos, and A. Forrest. 1994. Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis. Antimicrob. Agents Chemother. 38:2024-2028.
11. Capparelli, E. V., J. R. Lane, G. L. Romanowski, E. J. McFeely, W. Murray, P. Sousa, C. Kildoo, and J. D. Connor. 2001. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J. Clin. Pharmacol. 41:927-934.
12. Charles, B. G., Y. Preechagoon, T. C. Lee, P. A. Steer, V. J. Flenady, and N. Debuse. 1997. Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants. J. Pharm. Sci. 86:1288-1292.
13. Cuzzolin, L., V. Fanos, D. Zambreri, E. M. Padovani, and G. Benoni. 1991. Pharmacokinetics and renal tolerance of aztreonam in premature infants. Antimicrob. Agents Chemother. 35:1726-1728.
14. Deguchi, Y., R. Koshida, E. Nakashima, R. Watanabe, N. Taniguchi, F. Ichimura, and A. Tsuji. 1988. Interindividual changes in volume of distribution of cefazolin in newborn infants and its prediction based on physiological pharmacokinetic concepts. J. Pharm. Sci. 77:674-678.
15. Drusano, G. L., and M. Hutchison. 1995. The pharmacokinetics of meropenem. Scand. J. Infect. Dis. 96:11-16.
16. Eicher, D. J., and D. J. Annibale. 2002. Neonatal sepsis: evaluation and management. J. S. C. Med. Assoc. 98:106-112.
17. Falcao, A. C., D. S. Buelga, M. E. Mendez, M. J. Garcia, and M. Pardo. 2001. Population kinetics of tobramycin in neonates. Ther. Drug Monit. 23:202-208.
18. Fawer, C. L., A. Torrado, and J. P. Guignard. 1979. Maturation of renal function in full-term and premature neonates. Helv. Paediatr. Acta 34:11-21.
19. Garcia-Capdevila, L., C. Lopez-Calull, C. Arroyo, M. A. Moral, M. A. Mangues, and J. Bonal. 1997. Determination of imipenem in plasma, by high-performance liquid chromatography for pharmacokinetic studies in patients. J. Chromatogr. B Biomed. Sci. Appl. 692:127-132.
20. Gilman, J. T., and P. Gal. 1992. Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier. Clin. Pharmacokinet. 23:1-9.
21. Gouyon, J. B., A. Pechinot, C. Safran, P. Chretien, D. Sandre, and A. Kazmierczak. 1990. Pharmacokinetics of cefotaxime in preterm infants. Dev. Pharmacol. Ther. 14:29-34.
22. Herngren, L., M. Ehrnebo, and U. Broberger. 1987. Pharmacokinetics of free and total flucloxacillin in newborn infants. Eur. J. Clin. Pharmacol. 32:403-409.
23. Haisman-de Boer, J. J., J. N. van den Anker, M. Vogel, W. H. Goessens, R. C. Schoemaker, and R. de Groot. 1995. Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks. Antimicrob. Agents Chemother. 39:431-434.
24. Jasso-Gutierrez, L., H. Villasenor-Acosta, O. Falcon, and E. Diaz del Castillo. 1976. Glomerular filtration rate in newborn infants. Arch. Investig. Med. 7:91-96.
25. Kacet, N., M. Roussel-Delvallez, C. Gremillet, J. P. Dubos, L. Storme, and P. Lequien. 1992. Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age. Pediatr. Infect. Dis. J. 11:365-369.
26. Karna, P., C. Lee, A. Kumar, J. Dyke, and W. M. Gooch III. 1993. Population pharmacokinetics of ceftizoxime in premature newborns. Dev. Pharmacol. Ther. 20:135-143.
27. Kimura, T., H. Kokubun, M. Nowatari, N. Matsuura, K. Sunakawa, and H. Kubo. 2001. Population pharmacokinetics of panipenem in neonates and retrospective evaluation of dosage. J. Antimicrob. Chemother. 47:51-59.
28. Kubo, H., Y. Kobayashi, and T. Nishikawa. 1985. Rapid method for determination of kanamycin and dibekacin in serum by use of high-pressure liquid chromatography. Antimicrob. Agents Chemother. 28:521-523.
29. Malcolm, G. C. 1985. Maturation of glomerular filtration in preterm and mature babies. Early Hum. Dev. 11:281-292.
30. Martin, E., J. R. Koup, U. Paravicini, and K. Stoeckel. 1984. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J. Pediatr. 105:475-481.
31. Mitomi, N., T. Matsumoto, M. Fujigaki, I. Komiya, and F. Kai. 1987. Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats. Jpn. J. Antibiot. 40:357-364.
32. Mulhall, A., J. de Louvois, and J. James. 1985. Pharmacokinetics and safety of ceftriaxone in the neonate. Eur. J. Pediatr. 144:379-382.
33. Mullaney, D. W. 2001. Group B streptococcal infections in newborns. J. Obstet. Gynecol. Neonatal Nurs. 30:649-658.
34. Naganuma, H., H. Tokiwa, Y. Hirouchi, Y. Kawahara, J. Fukushige, and M. Fukami. 1991. Nephroprotective effect and its mechanism of betamipron. 1. Relationships of renal transport. Nippon Kagaku Ryoho Gakkai Zasshi 39:166-177.
35. Paap, C. M., and M. C. Nahata. 1990. Clinical pharmacokinetics of antibacterial drugs in neonates. Clin. Pharmacokinet. 19:280-318.
36. Padovani, E. M., C. Pistolesi, V. Fanos, A. Messori, and N. Martini. 1993. Pharmacokinetics of amikacin in neonates. Dev. Pharmacol. Ther. 20:167-173.
37. Peterson, L. R., and D. N. Gerding. 1980. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev. Infect. Dis. 2:340-348.
38. Philips, J. B., III, K. Braune, W. Ravis, G. Cassady, and H. Dillon. 1984. Pharmacokinetics of cefoperazone in newborn infants. Pediatr. Pharmacol. 4:193-197.
39. Reed, M. D., R. M. Kliegman, T. S. Yamashita, C. M. Myers, and J. L. Blumer. 1990. Clinical pharmacology of imipenem and cilastatin in premature infants during the first week of life. Antimicrob. Agents Chemother. 34:1172-1177.
40. Rule, R., N. J. Martiarena, M. Rubio, and A. Magadan. 1993. Pharmacokinetics of ceftazidime in newborn infants. Medicina 53:207-210.
41. Sawchuk, R. J., and D. E. Zaske. 1976. Pharmacokinetics of dosing regimens which use multiple intravenous infusions: gentamicin in burn patients. J. Pharmacokinet. Biopharm. 4:183-195.
42. Schwartz, G. J., L. P. Brion, and A. Spitzer. 1987. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr. Clin. N. Am. 34:571-590.
43. Shaffer, S. G., S. K. Bradt, V. M. Meade, and R. T. Hall. 1987. Extracellular fluid volume changes in very low birth weight infants during first 2 postnatal months. J. Pediatr. 111:124-128.
44. van den Anker, J. N., R. C. Schoemaker, W. C. Hop, B. J. van der Heijden, A. Weber, P. J. Sauer, H. J. Neijens, and R. de Groot. 1995. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin. Pharmacol. Ther. 58:650-659.
45. van den Anker, J. N., W. C. Hop, R. C. Schoemaker, B. J. van der Heijden, H. J. Neijens, and R. de Groot. 1995. Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin. Br. J. Clin. Pharmacol. 40:439-443.
46. van Enk, J. G., D. J. Touw, and H. N. Lafeber. 2001. Pharmacokinetics of meropenem in preterm neonates. Ther. Drug Monit. 23:198-201.
47. Vicente, M. V., T. Olay, M. C. Quecedo, and A. Rodriguez. 1979. Diffusion of beta-lactam antibiotics and fosfomycin to interstitial tissue fluid in rabbits. Chemotherapy (Basel) 25:329-335.
48. Whiting, B., A. W. Kelman, and J. Grevel. 1986. Population pharmacokinetics. Theory and clinical application. Clin. Pharmacokinet. 11:387-401.
49. Winter, M. E. 1991. Basic clinical pharmacokinetics. Applied Therapeutics Inc., Vancouver, Wash.